The molecular approaches to distal renal tubular acidosis (dRTA) associated AE1 mutations lead us to understand the genetic and pathophysiological aspects of the acidification defects. An unanticipated high value of the urine-blood (U-B) PCO 2 after NaHCO 3 loading observed in a case of dRTA and southeast Asian ovalocytosis (SAO) might be from a mistarget of the AE1 to the luminal membrane of type A intercalated cells. The mutations of the AE1 gene resulted in SAO and also affected renal acidification function. Notwithstanding, after the NH4Cl loading in 20 individuals with SAO, the acidification in the distal nephron was normal. The presence of both SAO and G701D mutations of AE1 gene would explain the abnormal urinary acidification in the patients with the compound heterozogosity. In terms of the effect of the mutations on trafficking of AE1, truncated kidney isoform (kAE1) of wild-type showed a `dominant-positive effect' in rescuing the recessive mutant kAE1 (S773P or G701D) trafficking to the plasma membrane, in contrast with the dominant mutant kAE1 (R589H) resulting in a `dominantnegative effect' when heterodimerized with the wild-type kAE1. It is notable that the dominant mutants kAE1 (R901X or G609R) expression in MDCK cells clearly results in aberrant surface expression with some mutant protein appearing at the apical membrane. These might result in net bicarbonate secretion and increasing U-B PCO 2 in the distal nephron. The molecular physiological and genetic approaches have permitted identification of the molecular defects, predominantly in transporter proteins, and should in turn prompt development of novel therapeutic strategies.
Introduction
To maintain acid-base homeostasis, the kidney must reclaim all filtered bicarbonate (HCO 3¯) and regenerate new HCO 3¯ by excreting net acid sufficient in quantity to match that produced by systemic metabolism. The net acid excretion is mediated largely by energy-dependent . dRTA is highly prevalent in the northeast of Thailand and has been given the name endemic dRTA 4) . There was a spectrum of tubulointerstitial abnormalities ranging from suspected to overt dRTA in the geographic area. Possible environmental insults such as potassium (K + ) deficiency, might be the important pathogenic factor of endemic dRTA in the northeast of Thailand 5) . Notwithstanding, familial dRTA inherited in both autosomal dominant (AD) and autosomal recessive (AR) pattern [6] [7] [8] [9] [10] [11] , have been reported in different kindreds with primary dRTA.
Some patients remain asymptomatic until adolescence or adulthood, whereas others may be severely affected in infancy, with impaired growth and early nephrocalcinosis causing eventual renal insufficiency. Our studies 2, 4) showed that the endemic dRTA was also seen in children in the northeast of Thailand and had familial tendency.
In the past decade, the molecular genetic approach of positional cloning and candidate gene analysis have been combined to identify the genes responsible for these inherited conditions 12, 13) and have enhanced our understanding of normal renal physiology. This review will demonstrate the molecular approach for the cases of dRTA in Thailand in order to understand the genetic causes of primary inherited dRTA. It will, in addition, evaluate the ability of known functional and biochemical properties of these mutant proteins to explain the pathophysiology of associated renal acidification defects.
A case of dRTA and southeast Asian ovalocytosis (SAO)
We had reported a case of dRTA and SAO from the southern part of Thailand 14) . The patient was a 33-yearold woman who presented with 4 months of generalized muscle weakness. Only she and her father had SAO. Her principal laboratory findings were hypokalemic metabolic acidosis and a normal anion gap in her plasma ( Table 1) .
The results showed hypokalemia with a relatively high transtubular K + gradient (TTKG) and K + excretion rate, a relatively low rate of excretion of NH 4 + and high urine pH (>5.5) during hyperchloremic metabolic acidosis. These are all typical for the a patient with dRTA 15) .
To investigate the pathogenesis of dRTA, urine-blood (U-B) PCO 2 after NaHCO 3 loading is a useful diagnostic tool to provide a qualitative reflection of the secretion of H + in type A intercalated cells of the distal nephron 16, 17) . After the bicarbonate loading of the patient with her urine pH up to 7.7, her U-B PCO 2 was increased for more than 25 mm Hg (27 mm Hg). The U-B PCO 2 in two patients with hereditary spherocytosis and incomplete dRTA coinherited with a mutation in the AE1 gene was also reported to have an increased U-B PCO 2 within the normal range after the bicarbonate loading 18) . There was an unanticipated high value for the U-B PCO 2 of the patients, perhaps the result of HCO 3¯ secretion, which itself could also reduce the net rate of secretion of H + in the distal nephron. The explanation might be from a mistarget of the Cl¯/HCO 3¯ exchanger 1 (AE1) from the basolateral membrane to the luminal membrane of the type A intercalated cells 14) .
How can the patient with SAO have dRTA?
SAO is common in parts of Southeast Asia and Melanesia with a prevalence reaching 30% in certain ethnic groups 19) . It has been shown that SAO results from an AE1 gene mutation, which decreases red cell membrane AE1 is also found in the basolateral membrane of the type A intercalated cells of renal collecting ducts, which is involved in H + secretion 22) . Kidney AE1 (kAE1) is transcribed from an alternative promoter resulting in the production in human kidney of an isoform that is missing the N-terminal 65 amino acids found in erythroid isoform (eAE1). Many studies and reviews 10, 11, 23, 24) have shown that mutations of AE1 gene affect renal acidification function. To examine the possibility, we studied the renal acidification of the subjects with SAO 24) . Table 2 provides the results after the short acid loading study by 
Compound heterozygosity of abnormal AE1 genes causes AR recessive dRTA in the patients with SAO
During the previous acid-loading studies, we also identified the two clinically affected unrelated patients in the families with dRTA and SAO 24) . The two patients showed a low rate of NH 4 + excretion and an inability to The patients (II-1) in both families had mobility shifts of The results showed that exon 11 had a deletion of 27 bp corresponding to codons 400 to 408 whereas exon 17 contained a nucleotide substitution of G to A in codon 701 (CGG→CAG), resulting in an amino acid change from glycine to aspartic acid (G701D, one point mutation).
The sequencing results also showed the presence of homozygous band 3 Memphis I.
Studies of the influx of [ . From the expression study of G701D mutation in Xenopus oocytes, it has also been shown that the mutant protein was not transported to the surface of the cell membrane 8) . However if the G701D mutation was co-expressed with glycophorin A, the erythroid band 3 chaperonin, both AE1 surface expression and AE1-mediated Cl¯ transport were rescued. Therefore, the presence of both SAO and G701D mutation of AE1 gene would have a greater effect to the type A intercalated cells than the presence of either mutation alone, and this would explain the abnormal urinary acidification in the patients with the compound heterozogosity.
The mechanism of Trafficking defect of mutant AE1 exchanger causing dRTA
To examine the effect of mutations on the trafficking of AE1 in the patient with dRTA, Kittanokom et al. 25) transiently transfected erythroid AE1 (eAE1) and truncated kidney isoform (kAE1) of the wild-type and a novel recessive showed decreased binding to an inhibitor affinity resin and increased sensitivity to proteases. The kAE1 G701D also exhibited defective trafficking to the plasma membrane.
The kAE1 S773P was able to form homodimers and heterodimers with wild-type kAE1 or with kAE1 G701D.
Heterodimers of the wild-type kAE1 with kAE1 S773P or G701D could be delivered to the plasma membrane.
Whereas, the study of Quilty JA, et al. This review demonstrated how to make it possible to evaluate and elucidate genotype-phenotype relationships and should in turn prompt development of novel therapeutic strategies.
